Paradigm Biopharmaceuticals Ltd. has released a press release.
Continuation of Suspension from Quotation
Earlier from Paradigm Biopharmaceuticals
- Continuation of Voluntary Suspension
- Agreement to Return US$2M to Obsidian
- Phase 3 Interim Result Below Continuation Threshold
- Suspension from Quotation